Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -62,113 | -11,148 | -11,697 | -3,370 |
| Depreciation Amortization | 5,326 | 11,522 | 8,447 | 672 |
| Accounts receivable | 797 | -380 | -4,805 | -444 |
| Other Working Capital | -3,960 | -7,328 | -4,419 | -3,037 |
| Other Operating Activity | 57,816 | 5,806 | 15,834 | 444 |
| Operating Cash Flow | $-2,135 | $-1,529 | $3,360 | $-5,735 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -34,977 | -25,894 | N/A | N/A |
| PPE Investments | -2,710 | -3,764 | -4,068 | -1,112 |
| Net Acquisitions | N/A | -14,701 | -2,322 | N/A |
| Purchase Sale Intangibles | -2,212 | -2,127 | -144 | N/A |
| Other Investing Activity | -1,959 | -1,091 | -2,815 | -4,782 |
| Investing Cash Flow | $-39,646 | $-45,450 | $-9,204 | $-5,894 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | N/A | 2,000 | 4,000 |
| Debt Issued | 250 | 969 | 1,485 | N/A |
| Debt Repayment | -1,258 | -797 | -2,975 | -206 |
| Common Stock Issued | 158 | 425 | 94,938 | 5 |
| Common Stock Repurchased | N/A | -119 | N/A | N/A |
| Other Financing Activity | 240 | 0 | 5,005 | 0 |
| Financing Cash Flow | $-610 | $478 | $100,453 | $3,800 |
| Exchange Rate Effect | -216 | -274 | 197 | N/A |
| Beginning Cash Position | 50,916 | 97,690 | 2,885 | 10,715 |
| End Cash Position | 8,309 | 50,916 | 97,690 | 2,885 |
| Net Cash Flow | $-42,606 | $-46,775 | $94,806 | $-7,830 |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,135 | -1,529 | 3,360 | -5,735 |
| Capital Expenditure | -2,710 | -3,764 | -4,068 | -1,112 |
| Free Cash Flow | -4,845 | -5,292 | -708 | -6,848 |